These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 3129103)
1. Sulphonylureas and hypoglycaemia. Ferner RE; Neil HA Br Med J (Clin Res Ed); 1988 Apr; 296(6627):949-50. PubMed ID: 3129103 [No Abstract] [Full Text] [Related]
3. Octreotide treatment for sulfonylurea-induced hypoglycaemia. Crawford BA; Perera C Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835 [No Abstract] [Full Text] [Related]
4. Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis. Salvo F; Moore N; Arnaud M; Robinson P; Raschi E; De Ponti F; Bégaud B; Pariente A BMJ; 2016 May; 353():i2231. PubMed ID: 27142267 [TBL] [Abstract][Full Text] [Related]
6. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas. Stahl M; Berger W Diabet Med; 1999 Jul; 16(7):586-90. PubMed ID: 10445835 [TBL] [Abstract][Full Text] [Related]
7. Inclusion of the EXAMINE study in a meta-analysis of the addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia. Boucaud-Maitre D BMJ; 2016 Jun; 353():i3186. PubMed ID: 27267596 [No Abstract] [Full Text] [Related]
13. Prevalence of factitious hypoglycaemia associated with sulphonylurea drugs in France in the year 2000. Trenque T; Frances C; Millart H; Hoizey G; Germain ML Br J Clin Pharmacol; 2002 Nov; 54(5):548. PubMed ID: 12445037 [No Abstract] [Full Text] [Related]
14. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients. Halimi S Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635 [No Abstract] [Full Text] [Related]
15. Comment: "Quantitative insulin and C peptide levels among ED patients with sulfonylurea-induced hypoglycemia". Livshits Z; Hoffman RS Am J Emerg Med; 2011 Sep; 29(7):812-3. PubMed ID: 21872103 [No Abstract] [Full Text] [Related]
16. Using pharmacoepidemiological findings to guide clinical practice: sulfonylureas and hypoglycemia in older adults. Gurwitz JH J Am Geriatr Soc; 1996 Jul; 44(7):871-2. PubMed ID: 8675941 [No Abstract] [Full Text] [Related]
17. Comparative tolerability of sulphonylureas in diabetes mellitus. Harrower AD Drug Saf; 2000 Apr; 22(4):313-20. PubMed ID: 10789825 [TBL] [Abstract][Full Text] [Related]